Reported Earnings • Aug 07
First quarter 2027 earnings released: EPS: JP¥35.51 (vs JP¥33.28 in 1Q 2026) First quarter 2027 results: EPS: JP¥35.51 (up from JP¥33.28 in 1Q 2026). Revenue: JP¥41.4b (up 5.4% from 1Q 2026). Net income: JP¥2.54b (up 3.8% from 1Q 2026). Profit margin: 6.1% (down from 6.2% in 1Q 2026). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Declared Dividend • Jul 25
Final dividend of JP¥18.00 announced Shareholders will receive a dividend of JP¥18.00. Ex-date: 29th September 2026 Payment date: 25th November 2026 Dividend yield will be 2.6%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (34% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 17% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Jun 23
Full year 2026 earnings: EPS exceeds analyst expectations Full year 2026 results: EPS: JP¥106 (up from JP¥87.80 in FY 2025). Revenue: JP¥158.5b (up 5.2% from FY 2025). Net income: JP¥7.71b (up 18% from FY 2025). Profit margin: 4.9% (up from 4.3% in FY 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.5%. Revenue is forecast to grow 6.1% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. 공고 • Jun 19
ZACROS Corporation Announces Board and Committee Changes, Effective June 19, 2026 ZACROS Corporation Announces directorate and committee changes, Effective June 19, 2026. The company announced the retirement of Eishi Fuyama as director. Manabu Sakai as Outside Director, Audit and Supervisory Committee Member. Ms. Kumi Izawa was elected as a Director who is an Audit and Supervisory Committee Member at the Annual General Meeting of Shareholders held June 19, 2026. Ms. Satoko Takeuchi was elected as a Director at the Annual General Meeting of Shareholders held June 19, 2026. Company announced election of Kumi Izawa as Audit and Supervisory Committee Member and Shoji Hatano as Audit and Supervisory Committee Member, effective June 19, 2026. Career Summary of Newly Elected Director: Name: Shoji Hatano Date of Birth: July 27, 1959 New Position: Outside Director, Audit and Supervisory Committee Member Number of Shares: 2,000 shares (as of March 31, 2026). He joined Terumo Corporation in April 1983 and has held a series of senior leadership roles within the organization. In June 2009, he was appointed Executive Officer and General Manager of the Secretarial Office, followed by his promotion to Senior Executive Officer and General Manager of the Corporate Planning Office in June 2012. In April 2015, he became Managing Executive Officer, and in April 2016, he was appointed Director and Managing Executive Officer while also serving as President of Medical Care Solutions. He advanced to Director and Senior Managing Executive Officer in April 2022. In addition to his roles at Terumo, he has served as an Outside Director of Stanley Electric Co. Ltd. since June 2025, which remains his current position, and is set to serve as an Outside Director and Audit and Supervisory Committee Member at ZACROS Corporation from June 2026. He holds significant concurrent roles, including his position at Stanley Electric Co. Ltd., and has no conflicts of interest with the Company. He is expected to be designated as an Independent Officer. His selection is based on his extensive experience in formulating and promoting corporate management policies and strategies, as well as his strong knowledge of corporate management, which the Company believes will contribute effectively to its management oversight and auditing functions. Masaru Saito has been appointed as Head of Corporate Strategy & Planning, with additional responsibilities as Chief Manager of Corporate Strategy & Planning and Manager of the Corporate Strategy & Planning Group, transitioning from his previous role as Chief Manager, Corporate Strategy & Planning and Manager of the Corporate Strategy & Planning Group. Effective June 19, 2026. Reported Earnings • May 09
Full year 2026 earnings: EPS exceeds analyst expectations Full year 2026 results: EPS: JP¥106 (up from JP¥87.80 in FY 2025). Revenue: JP¥158.5b (up 5.2% from FY 2025). Net income: JP¥7.71b (up 18% from FY 2025). Profit margin: 4.9% (up from 4.3% in FY 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.5%. Revenue is forecast to grow 6.1% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 24% per year whereas the company’s share price has increased by 21% per year. 
